© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
February 23, 2021
The approval of the first-line treatment was granted to Regeneron Pharmaceuticals.
January 22, 2021
Alliance will provide insight, education, and training opportunities to pharmaceutical and life sciences professionals.
January 01, 2021
The market for acute lymphocytic leukemia and bladder cancer drug therapies is expected to soar over the next few years, thanks in part to new and innovative medications.
December 09, 2020
A new online tool allowing AllianceRx Walgreens Prime oncology patients to refill their own prescriptions saves time, while still providing pharmacists’ help when needed.
December 04, 2020
The FDA approved azacitidine tablets (Onureg; Celgene Corporation) on September 1, 2020
November 19, 2020
Gut bacteria may be partially responsible for metabolic changes that lead to weight gain following chemotherapy treatment, according to a recent study.
November 17, 2020
The phase 1b clinical trial combined olaparib with capivasertib to treat patients with germline BRCA1/2 mutations and BRCA1/2 wild-type cancers.
The FDA approved Merck's blockbuster cancer drug, pembrolizumab (Keytruda), in combination with chemotherapy, to treat locally recurrent unresectable or metastatic triple-negative breast cancer.
November 16, 2020
How community pharmacists can advance care as patients come home.
November 10, 2020
Pharmacists-in-training have a valuable impact on cancer care, according to authors of a recent journal article.